Novel bimodal bifunctional ligands for radioimmunotherapy and targeted MRI. (Q36813571)

16 August 2017

Novel bimodal bifunctional ligands for radioimmunotherapy and targeted MRI. (English)

1 reference

16 August 2017

Hyun-Soon Chong

1

1 reference

16 August 2017

Hyun A Song

2

1 reference

16 August 2017

Xiang Ma

3

1 reference

16 August 2017

Diane E Milenic

4

1 reference

16 August 2017

Erik D Brady

5

1 reference

16 August 2017

Sooyoun Lim

6

1 reference

16 August 2017

Haisung Lee

7

1 reference

16 August 2017

Kwamena Baidoo

8

1 reference

16 August 2017

Dengfeng Cheng

9

1 reference

16 August 2017

Martin W Brechbiel

10

1 reference

16 August 2017

20 June 2008

1 reference

16 August 2017

Bioconjugate Chemistry

1 reference

16 August 2017

19

1 reference

16 August 2017

7

1 reference

16 August 2017

1439-1447

1 reference

Rational design and generation of a bimodal bifunctional ligand for antibody-targeted radiation cancer therapy

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2497452

Next generation, high relaxivity gadolinium MRI agents

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2497452

Current status of therapy of solid tumors.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2497452

Antibody-targeted radiation cancer therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2497452

Protein measurement with the Folin phenol reagent

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2497452

Safety and efficacy of radioimmunotherapy with yttrium 90 ibritumomab tiuxetan (Zevalin).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2497452

Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2497452

Tumor therapy with targeted atomic nanogenerators

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2497452

Recent advances in radionuclide therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2497452

The development of the alpha-particle emitting radionuclides 212Bi and 213Bi, and their decay chain related radionuclides, for therapeutic applications

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2497452

HER-2/neu as a therapeutic target in non-small cell lung cancer, prostate cancer, and ovarian cancer.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2497452

Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2497452

Clinical radioimmunotherapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2497452

Prevention of radiolysis of monoclonal antibody during labeling.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2497452

Development of a spectroscopic assay for bifunctional ligand-protein conjugates based on copper

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2497452

A facile, water-soluble method for modification of proteins with DOTA. Use of elevated temperature and optimized pH to achieve high specific activity and high chelate stability in radiolabeled immunoconjugates

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2497452

Efficient synthesis and evaluation of bimodal ligand NETA.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2497452

Synthesis and biological evaluation of novel macrocyclic ligands with pendent donor groups as potential yttrium chelators for radioimmunotherapy with improved complex formation kinetics

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2497452

Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2497452

Effects of gadolinium chloride on the rat lung following intratracheal instillation

5 September 2018

1 reference

12 December 2020

How to determine free Gd and free ligand in solution of Gd chelates. A technical note

1 reference

12 December 2020

Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging

1 reference

12 December 2020

In vitro and in vivo evaluation of novel ligands for radioimmunotherapy

1 reference

12 December 2020

Identifiers

DOI

10.1021/BC800050X

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

18564868

1 reference